Business Today

THE INDIAN HAND

10 Vaccines in human clinical trial stage

124 Projects globally in hunt of Covid-19 vaccine

20 Projects in India at pre-clinical stage

By Winter. This is the ambitious target set by scientists to defeat Covid-19.

Regulators, scientists and life sciences companies are working at break-neck speed in what has become the largest and fastest vaccine/drug hunt in human history.

Biotech specialists are using all available platforms or vehicles – dead, artificially engineered and live viruses, apart from DNA- or RNA-based ones – to transport virus-killing antigens into human cells. Big pharmaceutical companies such as Pfizer, Novartis and GlaxoSmithKline are collaborating with each other. They have also opened their patented libraries of drug knowledge to researchers and academia. Governments and philanthropists are pumping in billions of dollars into promising projects. Scientists are attempting hundreds of treatment options from novel plasma and antigen injections to reusing old molecules right from Made in India anti-malarial hydroxychloroquine to HIV anti-virals to psoriasis or hepatitis drugs.

Normally, it takes four-six years to launch a vaccine right from developing a candidate and animal trials to three-stage human trials. The time to bring a drug to market is ten years.

You’re reading a preview, subscribe to read more.

More from Business Today

Business Today1 min read
Read Credible, Exclusive, And Insightful Business Stories
Subscribe and get upto 81% discount*
Business Today1 min read
Not Exactly Broad-based
MUMBAI ACCOUNTED FOR 68% OF THE CASH SEGMENT TURNOVER ON NSE AND 40% ON BSE IN FY23 AHMEDABAD’S SHARE HAS ALSO BEEN PROGRESSIVELY RISING OVER THE YEARS SHARE OF TOWNS OUTSIDE THE TOP 10 FELL IN FY23 ONLY FOUR STATES HAVE OVER 10 MILLION REGISTERED IN
Business Today1 min read
Action And Reaction
1 The gold loans market has witnessed significant growth, with compound annual growth rate of 22.7% in the three years to FY23 2 The gold loans outstanding of banks and NBFCs was ₹6.1 lakh crore as of FY23, per a Nirmal Bang report 3 The average gros

Related Books & Audiobooks